HARP - Harpoon Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $52.22. This is a potential upside of $29.21 (126.94%) from yesterday's end of day stock price of $23.01.

Harpoon Therapeutics's activity chart (see below) currently has 69 price targets and 58 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 43.64% with an average time for these price targets to be met of 208.27 days.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 25-Feb-2024. First documented stock forecast 04-Mar-2019.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$13

$-10.01 (-43.50%)

$13

1 years 8 months 2 days ago
(25-Feb-2024)

3/9 (33.33%)

$-9.93 (-43.31%)

216

Hold

$23

$-0.01 (-0.04%)

$20

1 years 9 months 19 days ago
(08-Jan-2024)

4/5 (80%)

$0.64 (2.86%)

215

Hold

$23

$-0.01 (-0.04%)

$12

1 years 9 months 20 days ago
(07-Jan-2024)

3/4 (75%)

$0.64 (2.86%)

43

Buy

$12

$-11.01 (-47.85%)

1 years 10 months 15 days ago
(12-Dec-2023)

1/2 (50%)

$2.54 (26.85%)

9

Buy

$70

2 years 6 months 27 days ago
(30-Mar-2023)

0/5 (0%)

$50 (250.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HARP (Harpoon Therapeutics) average time for price targets to be met?

On average it took 208.27 days on average for the stock forecasts to be realized with a an average price target met ratio 43.64

Which analyst has the current highest performing score on HARP (Harpoon Therapeutics) with a proven track record?

YIGAL NOCHOMOVITZ

Which analyst has the most public recommendations on HARP (Harpoon Therapeutics)?

Yigal Nochomovitz works at CITI and has 28 price targets and 18 ratings on HARP

Which analyst is the currently most bullish on HARP (Harpoon Therapeutics)?

Michael Ulz with highest potential upside - $326.99

Which analyst is the currently most reserved on HARP (Harpoon Therapeutics)?

Robert Driscoll with lowest potential downside - -$16.01

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?